Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka, Steven M. Devine, Jared L. Klein, Daniel Weisdorf, Joseph W. Fay, Auayporn Nademanee, Joseph H. Antin, Neal P. Christiansen, Richard Van der Jagt, Roger H. Herzig, Mark R. Litzow, Steven N. Wolff, Walter L. Longo, Finn B. Petersen, Chatchada Karanes, Belinda Avalos, Rainer Storb, Donald N. BuellRochelle M. Maher, William E. Fitzsimmons, John R. Wingard

Research output: Contribution to journalArticlepeer-review

431 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds